| Title: | Genesis Research & Development Corporation |
| Price: | $100.00 |
| Publication Date: | Aug 11, 2008 |
| Abstract: | Datamonitor's Genesis Research & Development Corporation Company Profile is the essential source for top-level company data and information. The report examines the company's key business structure and operations, history and products, and provides summary analysis of its key revenue lines and strategy.
Genesis Research & Development Corporation (Genesis) is a biotechnology company that is involved in the research and development of drug therapies for immune disorders and cancer. The company primarily operates in New Zealand where it is headquartered in Auckland and employs about 140 people. The company recorded revenues of NZ$776 thousands (approximately $571.5 thousands) in the fiscal year ended December 2007, a decrease of 28.3% compared to 2006. The company's operating profit was NZ$5,091 thousands (approximately $3,749 thousands) in fiscal year 2007, as compared to the operating loss of NZ$5,172 thousands (approximately $3,809.1 thousands) in 2006. Its net loss was NZ$764 thousands (approximately $562.7 thousands) in fiscal year 2007, as compared to the net profit of NZ$3,277 thousands (approximately $2,413.5 thousands) in the year 2006. Financials for the group considered Page 17 - Financials
Scope of the Report
- Provides all the crucial company information required for business and competitor intelligence needs
- Data is supplemented with details on the company's history, key executives, business description, locations and subsidiaries as well as a list of products and services and the latest available company statement.
Reasons to Purchase
- Support sales activities by understanding your customers' businesses better
- Qualify prospective partners and suppliers
- Keep fully up to date on your competitors' business structure, strategy and prospects
- Obtain the most up to date company information available |
| Brief Excerpt: | ...Genesis Research and De velopment is a biotechnology compan y which oper ates in genomics and immunology.The compan y is headquar tered in A uckland, Ne w Zealand. The compan y recorded re venues of NZD##.# million (appro ximately $#.# million) dur ing the fiscal year ended December ####, an increase of ###.#% o ver ####. The net profit w as NZD#.# million (approximately $#.# million) in fiscal y ear ####, as compard to a net loss of NZD#.# million (approximately $# million) dur ing ####. ... |
| Word Count: | 4844 |
| Length: | 16 Pages |
| Format: | 
Adobe Acrobat
|
| Free Sample: |
Click
Here
to Download
|
Looking For Something Else?
